Why Your Clinical Trial Is Struggling to Recruit — and How to Fix It
- Guy hudson
- 6 days ago
- 3 min read
Recruitment delays are one of the most common reasons clinical trials fall behind.
You may have a strong protocol, experienced sites, and full funding. Yet enrolment still moves slowly. When that happens, most teams try to fix the problem later.
But the truth is simple. Most recruitment issues are created early — before a single patient is contacted.
Where Things Usually Go Wrong
Slow recruitment rarely starts with patient outreach.
It often comes from early assumptions about how many patients are available and how easy they are to reach.
Common issues include:
Overestimating the eligible patient pool
Choosing sites without direct access to those patients
Relying on outdated or limited data
Leaving recruitment planning too late
These problems do not always show up immediately. But once recruitment begins, the impact becomes clear.
Why Feasibility Can Mislead You
Feasibility is meant to guide the study.
But if it is based on estimates instead of real access, it creates risk.
A condition may look common, but strict criteria can reduce the actual pool. Patients may exist, but not near your selected sites. Or the pathway to reach them may be slower than expected.
Without early validation, you only discover these gaps after timelines start slipping.
The Cost of Fixing It Mid-Study
When recruitment falls behind, teams often react quickly.
They may:
Open more sites
Expand regions
Increase outreach efforts
These actions can help, but they are expensive and often too late.
They fix symptoms, not the root cause.
What Actually Works
Better recruitment starts earlier.
It comes from knowing where your patients are and how to reach them before the study begins.
A stronger approach includes:
Access to real patient populations
This allows you to validate feasibility with confidence.
Smarter site selection
Sites should match where patients are, not just where capacity exists.
Early recruitment planning
Recruitment should be built into study design, not added later.
TrialChoices supports this by connecting research teams with UK patients through primary and secondary care. This helps identify suitable participants faster and more accurately.
Why Speed Needs Accuracy
Fast recruitment sounds ideal.
But speed without accuracy creates more problems — especially high screening failure rates and wasted effort.
The goal is simple: Find the right patients, quickly.
That balance is what keeps studies moving smoothly.
The Importance of a Strong Start
Early recruitment sets the tone.
If enrolment starts slowly, it becomes harder to recover. Costs rise, timelines extend, and pressure builds across teams.
But when recruitment starts strong, everything becomes easier to manage.
That is why early access to patient data can make such a difference.
Signs Your Strategy Needs to Change
Some issues are clear warning signs:
Slow enrolment in the first phase
Difficulty finding eligible patients
High screening failures
Ongoing need to adjust strategy
If these appear, the issue is usually not effort — it is structure.
A Smarter Way Forward
Clinical trial recruitment is evolving.
The focus is shifting towards:
Earlier access to patient data
Closer links with healthcare providers
Faster study start-up
Better alignment between sites and patients
TrialChoices reflects this shift by helping connect global studies with UK patients through real healthcare pathways.
Final Thoughts
If your clinical trial is struggling to recruit, the issue likely started before recruitment began.
The solution is not just doing more. It is building a better foundation.
With stronger access to UK patient populations and better early planning, studies can avoid delays and move forward with confidence.
TrialChoices helps make that possible by connecting research teams with suitable patients faster and more efficiently.
Contact TrialChoices
If you want to improve recruitment and avoid delays from the start, TrialChoices can help.
Call +44 (0) 07711 248 610 or email info@trialchoices.org to learn how to access UK patients faster and keep your study on track.
Comments